Contact Information: Public and Investor Relations: Mercom Capital Group, llc tel: 1.512.828.6645 e-mail: Email Contact
Amber Pharmacy and ALR Technologies Team Up to Provide ALR Technologies' Constant Health Companion to Organ Transplant Patients
Amber Pharmacy Provides Specialized Care and Personal Solutions to Transplant Patients Nationwide
| Source: ALR Technologies, Inc.
WINSTON-SALEM, NC -- (MARKET WIRE) -- December 12, 2006 -- ALR Technologies, Inc. (OTCBB : ALRT )
announces they have reached agreement with Amber Pharmacy, based in Omaha,
NE, for Amber Pharmacy to provide the Constant Health Companion™ patient compliance system to
organ transplant patients across the nation. Amber Pharmacy provides
specialized care and personal solutions to thousands of transplant patients
in the U.S. They have offices in Omaha, Philadelphia, Dallas and Chicago.
According to Tim Kaplan, COO of Amber Pharmacy, transplant coordinators are
continuously asking about ways to improve their patients' compliance. "As
incredible as it may sound, many organ transplant recipients do not
adhere to their medication regimen and we are always talking to transplant
coordinators about ways to improve the patient's adherence. We're excited
about the potential for the Constant Health
Companion to bring this
much-needed service to the thousands of patients who receive the
life-sustaining organs. The ability to monitor the patient's compliance is
likewise essential because if a person is not being compliant we will know
about it much earlier than previously."
"Our plans are to begin offering the Constant Health Companion in February
of 2007 and in the meantime we'll be putting together a program for use
with our current patients and with our transplant program coordinators.
There are more than 30,000 new recipients of organs each year and the
availability of the Constant Health Companion can help change their lives."
The Constant Health Companion is a compliance reminder and monitoring
system that alerts the patient when it's time to take a medication or
treatment; displays the exact actions to take on a screen and the patients'
compliance can be remotely monitored by a health care provider. The
Constant Health Companion has been in use, with positive results, in pilots
with transplant patients since February 2006. Missed medications and
treatments or even lateness of administration can result in adverse affects
and complications. Losing a transplanted organ has the obvious health
effects with the patient as well as hundreds of thousands of dollars in
additional costs to health
insurance providers.
Noncompliance is widespread in recipients of life-sustaining organs and the
necessity for the patient to adhere to the medications and treatments is so
important due to the life-saving nature of the procedure. Patients who are
noncompliant with transplant medications have lower anti-rejection drug
levels, more acute rejection, and more chronic graft loss and
medication noncompliance is a leading cause of morbidity in pediatric
transplant recipients.
About Amber Pharmacy.
Amber Pharmacy focuses on the special needs of transplant patients and
those in other chronic disease states. Amber Pharmacy works with over 150
transplant centers throughout
the country in providing specialized care and personal solutions to
patients. By utilizing the services of Amber Pharmacy, patients achieve a
much higher compliance rate thus improving outcomes and lowering their
overall cost of healthcare. Amber Pharmacy has locations in Omaha, Dallas,
Chicago and Philadelphia. More information about Amber can be found at
their website http://www.amberpharmacy.com, or they can be reached by email
at amber@amberpharmacy.com.
About ALR Technologies, Inc.
ALR Technologies, Inc. (ALRT) specializes in health and disease management products and
services, and designs and manufactures health management compliance
products and compliance monitoring and intervention systems to meet the
needs for several targeted user groups. ALRT's system, branded Constant
Health Companion™, fills a serious gap in standard disease management
practices in the U.S. It provides for continued compliance oversight to
help keep people healthy, whether they suffer from diabetes, heart disease,
asthma, have had an organ transplant or other serious conditions. More
information on ALR Technologies and its products can be found at
http://www.alrt.com. More information about the Constant Health Companion
can be found at: http://www.alrt.com/products/alrt500.html.
This release contains certain "forward-looking statements" relating to ALR
Technologies' business, and these statements reflect the current views of
ALR Technologies with respect to future events and are subject to certain
risks, uncertainties and assumptions. When used, the words "estimate,"
"expect," "anticipate," "believe" and similar expressions are intended to
identify such forward-looking statements. There are many factors that
could cause the actual results, performance or achievements of ALR
Technologies and its products to be materially different from any future
results, performances or achievements that may be expressed or implied by
such forward-looking statements. Further management discussions of risks
and uncertainties can be found in the company's quarterly filings with the
Securities Exchange Commission.